Merck
MRK
#48
Rank
NZ$547.15 B
Marketcap
NZ$221.54
Share price
0.32%
Change (1 day)
67.83%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): NZ$6.00

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$6.08. In 2025 the company made an earnings per share (EPS) of NZ$12.44 an increase over its 2024 EPS that were of NZ$11.50.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.00-51.76%
2025NZ$12.448.15%
2024NZ$11.504308.46%
2023NZ$0.26-97.32%
2022NZ$9.7510.92%
2021NZ$8.7984.68%
2020NZ$4.76-27.2%
2019NZ$6.5463.44%
2018NZ$4.00151.11%
2017NZ$1.59-54.58%
2016NZ$3.5130.21%
2015NZ$2.69-61.99%
2014NZ$7.08180.51%
2013NZ$2.53-31.82%
2012NZ$3.706.62%
2011NZ$3.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.86 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.94 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.23-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.14 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.03 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.64 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.36-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$6.06-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.61 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.33-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel